Medical device tax more likely to raise prices than lower headcounts, survey says

MassDevice.com coverage of the medical device tax

Medical device makers are considering a few alternatives to deal with the impact of the new 2.3% medical device sales tax, with far more planning increases in product prices than expecting workforce reductions, according to a recent survey.

More than 40% of medtech companies surveyed said they plan to pass along either part or all of the cost of the tax to their customers and more than 30% said they were working on ways to lower production costs without resorting to layoffs. The results may be marred, however, by the 31% of respondents who either checked "other" or said that they were unable to disclose their plans.

The survey, conducted by Emergo Group, queried more than 3,000 medical device industry participants, isolating the medtech tax question to about 650 senior executives at companies in North and South America, most of them in the U.S. and Canada.

About 12% of those participants, who were able to select multiple options for how they would deal with the medical device tax, said they would trim research & development budgets and 11% said they would reduce their staff.

A little more than 1% said they would exit the U.S. market entirely.

Large companies, defined as those with 250 or more employees, were more likely to resort to layoffs, with nearly 13% reporting that they might lower headcounts. Only 10.4% of companies with 50-249 employees, 7% of companies with 10-49 employees and 5.5% of companies with fewer than 10 employees said they would do the same.

The large companies were also the least likely to hike prices, with 28.4% saying they would pass the tax on to customers. That compared with 34.9% of companies with 50-249 employees, 31.1% of companies with 10-49 employees and 34.1% of companies with fewer than 10 employees.

Industry lobbying groups have warned that about 43,000 medtech jobs may be lost as a result of the 2.3% medical device excise tax that took effect at the start of 2013.

Medical device tax opponents have long warned that the new levy on the industry, designed to generate federal revenue in support of President Barack Obama’s healthcare reform bill, would raise the cost of healthcare and force companies to lay off workers or put off hiring.

Some medical device purchasing groups have come out in protest of price increases, depicting the hikes as the medical device industry’s attempt to shift their fair share of the cost of healthcare reform to industries that are already paying their share.

GPOs have been wary of tax-related price hikes long before the tax took effect at the start of this year. In May 2012 GPO Premier urged the IRS to protect hospitals from price hikes by requiring device makers to promise that their tax burden isn’t baked into their prices.

The effort is not in vain, as a handful of older industry surveys have similarly found that medical device companies are looking for various ways to offset the cost of the medical device tax, including by raising prices for their products. A GPO protest, however, packs quite a punch. About 96%-98% of hospitals use some form of group purchasing and ¾ of hospital purchases are made through GPOs, according to HSCA.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply